Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 282-287

  Rose, Jim ^a   Rodrigues, George ^b,c   Yaremko, Brian ^b   Lock, Michael ^b   D'Souza, David ^b  

^a Kingston Regional Cancer Centre   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Dose volume histograms; Esophagitis; Lung cancer; Modeling; Systematic review

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADJUVANT THERAPY; BIBLIOGRAPHIC DATABASE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL STUDY; DOSIMETRY; ELECTRONIC MEDICAL RECORD; ESOPHAGITIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; THYMOMA; TREATMENT PLANNING;

DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGITIS; HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 65749102667     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.09.010     Document Type: Review

References (35)

1. Ahn S.J., Kahn D., Zhou S., Yu X., Hollis D., Shafman T.D., et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 61 (2005) 335-347
2. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
3. Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Semin Oncol 32 (2005) S111-S113
4. Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113
5. Chapet O., Kong F.M., Lee J.S., Hayman J.A., and Ten Haken R.K. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77 (2005) 176-181
6. Choy H., LaPorte K., Knill-Selby E., et al. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol 9 (1999) 90-96
7. Cox J.D., Le Chevalier T., Arriagada R., et al. Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer 42 (2003) S15-S16
8. Edelman M.J., Gandara D.R., Roach III M., et al. Multimodality therapy in stage III non-small cell lung cancer [published erratum appears in Ann Thorac Surg 1996 Dec;62(6):1892]. Ann Thorac Surg 61 (1996) 1564-1572
9. Graham M.V., Purdy J.A., Emami B., et al. 3-D conformal radiotherapy for lung cancer. The Washington University experience. Front Radiat Ther Oncol 29 (1996) 188-198
10. Herskovic A., Fisher J., Orton B., et al. Accelerated hyperfractionation in patients with non-small cell bronchogenic cancers as a cost-effective and user- and patient-friendly schedule. Cancer Invest 18 (2000) 537-543
11. Hirota S., Tsujino K., Endo M., Kotani Y., Satouchi M., Kado T., et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 51 2 (2001) 291-295
12. Kahn D., Zhou S., Ahn S., Hollis D., Yu X., D'Amico T., et al. Anatomically-correct dosimetric parameters may be better predictors for esophageal toxicity than are traditionally CT-based metrics. Int J Radiat Oncol Biol Phys 62 (2005) 645-651
13. Kim T.H., Cho K.H., Pyo H.R., Lee J.S., Han J.Y., Zo J.I., et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 995-1002
14. Koukourakis M.I., Flordellis C.S., Giatromanolaki A., et al. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis. Clin Cancer Res 5 (1999) 3970
15. Langer C., Movsas B., Hudes R., Schol J., Keenan E., Kilpatrick D., et al. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy inpatients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Semin Oncol 24 4 (1997) S12-S95
16. Maguire P.D., Marks L.B., Sibley G.S., et al. 73.6 Gy and beyond: hyperfractionated accelerated radiotherapy for non-small-cell lung cancer. J Clin Oncol 19 (2001) 705-711
17. Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45 (1999) 97-103
18. Martini N., Kris M.G., and Ginsberg R.J. The role of multimodality therapy in locoregional non-small cell lung cancer. Surg Oncol Clin N Am 6 (1997) 769-791
19. McGinnis W.L., Loprinzi C.L., Buskirk S.J., et al. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 15 (1997) 1239-1243
20. Mehta V. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer. Semin Oncol 31 (2004) 42-46
21. Movsas B., Moughan J., Komaki R., et al. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21 (2003) 4553-4559
22. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer [erratum appears in Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):921 Note: Change, Joe T [corrected to Chang, Joe T]]. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
23. Patel A.B., Edelman M.J., Kwok Y., et al. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60 (2004) 1106-1112
24. Qiao W.B., Zhao Y.H., Zhao Y.B., and Wang R.Z. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol 11 17 (2005) 2626-2629
25. Rosenman J.G., Halle J.S., Socinski M.A., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial [see comment]. Int J Radiat Oncol Biol Phys 54 (2002) 348-356
26. Rosenzweig K.E., Mychalczak B., Fuks Z., et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer [comment]. Cancer J 6 (2000) 82-87
27. Roswit B., Patno M.E., Rapp R., et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 90 (1968) 688-697
28. Sasso F.S., Sasso G., Marsiglia H.R., et al. Pharmacological and dietary prophylaxis and treatment of acute actinic esophagitis during mediastinal radiotherapy. Dig Dis Sci 46 (2001) 746-749
29. Schaake-Koning C. Radiotherapy in non-small cell lung cancer: optimal doses and schedules. Lung Cancer 12 (1995) S119-S123
30. Singh A.K., Lockett M.A., and Bradley J.D. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 337-341
31. Takeda K., Nemoto K., Saito H., et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 626-629
32. Takeda K., Nemoto K., Saito H., et al. Predictive factors for acute esophageal toxicity in thoracic radiotherapy. Tohoku J Exp Med 208 (2006) 299-306
33. Wei X., Liu H.H., Tucker S.L., et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 100-107
34. Werner-Wasik M., Langer C., and Movsas B. Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration. Semin Oncol 32 (2005) S105-S108
35. Xiao Y., Werner-Wasik M., Michalski D., et al. Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer. Med Dosim 29 (2004) 210-216